Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Monoferric injection for the treatment of iron deficiency anemia

Jan. 30, 2020

Novel cynomolgus macaque model for Sudan virus disease

Jan. 30, 2020

Dosing initiated in first-in-human study of IK-175

Jan. 30, 2020

Snake venom organoid gives toxin insights

Jan. 30, 2020

Avacta demonstrates proof of concept for TMAC platform in animal model of cancer

Jan. 29, 2020

CytoDyn explores use of leronlimab for novel coronavirus

Jan. 29, 2020

Clover begins development of recombinant subunit vaccine for 2019-nCoV

Jan. 29, 2020

Phase II study of AKCEA-ANGPTL3-LRx meets primary endpoint of significant triglyceride lowering

Jan. 29, 2020

Enrollment open in first-in-human study of CC-97540 in NHL

Jan. 29, 2020

Feisty old folks: Sprightly genomes bring insights into healthy aging, early-onset illness

Jan. 29, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...